HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
TBC-3711
Description
TBC3711 is a next-generation endothelin antagonist that is being studied through oral and intravenous formulations by Encysive Pharmaceuticals.
No brand information found.
